Explore This Lab

    Overview

    The Cellular and Molecular Immunology (CMI) Laboratory in the Center for Transplantation Sciences (CTS) at Massachusetts General Hospital is dedicated to:

    • Elucidating the mechanisms underlying the recognition of donor antigens by recipient lymphocytes after transplantation of allogeneic (from the same species) organs and tissues
    • Characterizing the nature of the cells and their mechanisms of action involved in the rejection or tolerance of allogeneic transplants

    Allorecognition is the ability of an organism to distinguish its own tissues from that of another. Our laboratory has developed a series of mouse models to study the different pathways of allorecognition (direct, indirect and semi-direct) by different T cell subsets (TH1, TH2, memory T cells and regulatory T cells), and the role of major histocompatability complex (MHC) cross-dressing and exosomes in the initiation and regulation of the immune responses leading to rejection or tolerance of allogeneic transplants.

    In addition, we are investigating donor cell trafficking after transplantation and the role of extracellular vesicles (exosomes) in the immune response leading to allograft rejection or tolerance. Based on this knowledge, we are attempting to design novel strategies to achieve tolerance of allografts (same-species transplants) in mice using skin, heart and pancreatic mouse transplant models.

    Additionally, our laboratory is studying the immune mechanisms underlying tolerance of organ transplants in non-human primates. We have recently demonstrated that pre-existing alloreactive memory T cells (donor-reactive memory T cells present in the host prior to transplantation) prevent tolerance of allografts in primates via costimulation blockade (blocking the signal for T-cell activation) and hematopoietic chimerism. We are currently characterizing the precise nature of these memory T cells and investigating the mechanisms by which they impair tolerance.

    Finally, we have recently detected the presence of large numbers of recipient cells displaying donor MHC molecules (MHC cross-dressed) on their surface in the blood of monkeys that are tolerant of kidney and heart transplants. We are investigating the role of exosomes and MHC cross-dressing intolerance maintenance.

    Based on this knowledge, we are designing clinically applicable strategies intended to selectively suppress these memory T cells and restore tolerance of kidney, heart and lung allografts in monkeys and patients.

    Lab Members

    Principal Investigator

    Gilles Benichou, PhD, DSc
    Immunologist, Massachusetts General Hospital
    Associate Professor of Surgery and Immunology, Harvard Medical School

    Gilles Benichou, PhD, DSc, is an associate professor of surgery and immunology at Harvard Medical School, senior immunologist at Mass General and head of the CMI Laboratory in the CTS at Mass General. Dr. Benichou is a basic scientist who received his doctorate in Immunology in 1987 at the Pasteur Institute and the University of Science in Paris, France, for his studies of cell surface signaling by anti-major histocompatability complex (MHC) antibodies. He also received his Doctor of Science from the University of Science in Paris in 1997. Since 1987, his research has been focused on the mechanisms underlying the recognition of self versus non-self antigens by the immune system in cancer and transplantation.

    Specifically, Dr. Benichou’s laboratory has shown the contribution of cryptic self-peptides to the induction of autoimmunity. Dominant and cryptic p53 peptides, which induce CD4+ T cell immune responses to tumors in mice and melanoma patients, have been identified and are currently being tested as cancer vaccines. In 1991, Dr. Benichou published the first article demonstrating the role of MHC-derived peptides in indirect alloreactivity during the course of allotransplant rejection.

    Since then, Dr. Benichou’s laboratory has been studying the cellular and molecular mechanisms underlying direct and indirect types of allorecognition, including post-transplant autoimmunity in mouse models. In 2001, Dr. Benichou was recruited to the Department of Surgery at Mass General to develop clinical protocols for tolerance induction to allotransplants in primates. His most recent research at Mass General has led to the demonstration that the donor-specific memory T cells that present in primates pre-transplantation represent a formidable barrier to transplant tolerance induction.

    Recently, Dr. Benichou’s studies revealed that primates displaying low frequencies of memory T cells against their donors could be successfully rendered tolerant of kidney allografts via the mixed chimerism protocol established at Mass General.

    Postdoctoral Research Fellows

    • Claire Guinier

    PhD Students

    • Natacha Carnel
    • Hyshem Lancia

    Research Projects

    The CMI Laboratory is leading the following research projects:

    Studies Using Mouse Models

    • Pathways of allorecognition by T cells: We are studying the contribution of direct, indirect and semi-direct allorecognition by T cells to the alloresponses involved in rejection and tolerance of allogeneic transplants. Recently, we showed the presence of recipient antigen presenting cells displaying donor major histocompatability complex (MHC) molecules after transplantation and are currently investigating the contribution of this phenomenon in the initiation and perpetuation of alloimmunity and rejection after skin and organ transplantation. In addition, we are investigating the trafficking of recipient and donor leukocyte subpopulations and their subcellular vesicles via blood and lymphatic vessels after transplantation using flow imaging and multiphoton intra-vital microscopy
    • Sensitization and tolerance to alloantigens mediated via materno-fetal relationships: Maternal blood cells regularly traffick to the fetus and neonate during pregnancy and breast feeding, respectively. Actually, this includes maternal hematopietic stem cells which give rise to maternal blood cells, which are present during the entire life of the offspring. Therefore, we carry both our immune system and that of our mother.  We are studying the mechanisms by which maternal hematopoietic chimerism influences autoimmune (autoimmune diseases) and alloimmune (transplant rejection) responses in the adult offspring
    • Contribution of “natural” and acquired memory T cells to rejection and tolerance resistance in transplantation: We have recently identified two distinct subtypes of memory T cells (cells induced after vaccination) called “natural” and “induced” TMEM. We are currently studying their functional properties and their contribution to transplant rejection and tolerance resistance using different mouse models. In addition, we are investigating the role of pro-inflammatory (Be) and regulatory (Bregs) B cells as antigen presenting cells in the generation and reactivation of memory T cells

    Studies Using Nonhuman Primate Models

    • Mechanisms underlying T and B cell responses to allogeneic transplants: In collaboration with James Allan, MD, Benedict Cosimi, MD, Tatsuo Kawai, MD, PhD, and Joren Madsen, MD, DPhil, we study the immune mechanisms underlying the rejection or tolerance of kidney, heart, lung and pancreatic islet allografts in non-human primates
    • Role of memory T and B cells to tolerance resistance in non-human primates: We have recently shown that the presence of memory T cells represents a major barrier tolerance to allogeneic transplants in non-human primates. We are currently studying the mechanisms by which memory T cells prevent tolerance to heart, lung, kidney and, pancreatic islet allografts in cynomolgus monkeys. In addition, we are attempting to design novel strategies to prevent or suppress selectively the activation of donor-specific memory T cells after transplantation and/or tolerance induction in primates

    Publications

      The Mass General Transplant Center

      is a destination for those requiring transplant, and is the only center in the region to offer adult transplantation for every organ.

      Learn more